Kane Biotech Inc. (KNBIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0371
0.00 (0.00%)
Jun 11, 2025, 8:00 PM EDT
Kane Biotech Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 6.28 | 6.1 | -5.03 | -3.89 | -4.6 | -3.72 | Upgrade
|
| Depreciation & Amortization | 0.21 | 0.22 | 0.24 | 0.26 | 0.19 | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.21 | 0.21 | 0.01 | 0 | 0.07 | 0.04 | Upgrade
|
| Stock-Based Compensation | 0.63 | 0.71 | 0.44 | 0.28 | 1.09 | 0.46 | Upgrade
|
| Other Operating Activities | -10.2 | -10.04 | 1.74 | 0.38 | -0.32 | -0.54 | Upgrade
|
| Change in Accounts Receivable | -0.09 | 0.02 | 0.01 | 0.46 | 0.04 | -0.28 | Upgrade
|
| Change in Inventory | 0.09 | -0.13 | -0.11 | -0.07 | -0.05 | 0.12 | Upgrade
|
| Change in Accounts Payable | -0.04 | 0.25 | 0.2 | -0.22 | 0.78 | 0.05 | Upgrade
|
| Change in Unearned Revenue | -0.89 | -0.94 | 0.55 | -0.09 | 0.51 | -0.07 | Upgrade
|
| Change in Other Net Operating Assets | -0.21 | -0.06 | -0.05 | 0.04 | 0.01 | -0.09 | Upgrade
|
| Operating Cash Flow | -4.23 | -4.11 | -2.08 | -3.04 | -2.29 | -3.94 | Upgrade
|
| Capital Expenditures | -0.03 | -0.02 | -0.01 | -0.01 | -0.19 | -0.03 | Upgrade
|
| Divestitures | 10.85 | 10.85 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.09 | -0.07 | -0.04 | -0.07 | -0.17 | -0.1 | Upgrade
|
| Other Investing Activities | -1.7 | -0.49 | 0.76 | -0.03 | -0.02 | -0.04 | Upgrade
|
| Investing Cash Flow | 9.02 | 10.27 | 0.71 | -0.11 | -0.37 | -0.17 | Upgrade
|
| Short-Term Debt Issued | - | - | 2 | 2.1 | 1.1 | 1.48 | Upgrade
|
| Long-Term Debt Issued | - | - | 0.01 | 0.68 | 0.69 | 0.91 | Upgrade
|
| Total Debt Issued | - | - | 2.01 | 2.78 | 1.8 | 2.39 | Upgrade
|
| Short-Term Debt Repaid | - | -6 | - | -0.4 | -0.46 | -0.02 | Upgrade
|
| Long-Term Debt Repaid | - | -0.65 | -0.48 | -0.13 | -0.09 | -0.02 | Upgrade
|
| Total Debt Repaid | -6.62 | -6.65 | -0.48 | -0.53 | -0.55 | -0.04 | Upgrade
|
| Net Debt Issued (Repaid) | -6.62 | -6.65 | 1.53 | 2.25 | 1.25 | 2.35 | Upgrade
|
| Issuance of Common Stock | 2.07 | 0.62 | 0.42 | 0.97 | 1.12 | 0.7 | Upgrade
|
| Other Financing Activities | -1.46 | -1.65 | 0.21 | -0.12 | 0.45 | 1.23 | Upgrade
|
| Financing Cash Flow | -6 | -7.69 | 2.16 | 3.1 | 2.81 | 4.28 | Upgrade
|
| Net Cash Flow | -1.21 | -1.53 | 0.78 | -0.05 | 0.15 | 0.17 | Upgrade
|
| Free Cash Flow | -4.26 | -4.14 | -2.09 | -3.05 | -2.48 | -3.97 | Upgrade
|
| Free Cash Flow Margin | -174.66% | -198.77% | -1403.79% | -1947.70% | -153.99% | -295.64% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.02 | -0.03 | -0.02 | -0.04 | Upgrade
|
| Cash Interest Paid | 0.8 | 0.96 | 0.26 | 0.62 | 0.05 | - | Upgrade
|
| Levered Free Cash Flow | -2.86 | -1.38 | -1.45 | -2.63 | -1.48 | -2.95 | Upgrade
|
| Unlevered Free Cash Flow | -2.68 | -1.04 | -0.69 | -2.12 | -1.22 | -2.87 | Upgrade
|
| Change in Net Working Capital | 1.09 | -0.44 | -0.77 | 0.41 | -0.86 | 0.68 | Upgrade
|
Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.